The State of Texas has intervened in a lawsuit against AstraZeneca for illegally promoting off-label uses of the drugs Seroquel and Seroquel XR. AstraZeneca has already been hit twice for off-label promotion of these drugs. In April 2010, the pharmaceutical company paid $520 million to settle allegation of off-label marketing of the drugs and in March 2011, paid $68.5 million to settle similar allegations.

State FCA | AstraZeneca, Texas, Scott Simmer, Brian Kenny, Tavy Deming, James Pepper